Stock ZYDUSLIFE ZYDUS LIFESCIENCES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Zydus Lifesciences Limited

Equities

ZYDUSLIFE

INE010B01027

Market Closed - NSE India S.E.
Other stock markets
 03:17:43 2024-05-18 am EDT 		5-day change 1st Jan Change
1,104 INR +5.00% Intraday chart for Zydus Lifesciences Limited +11.23% +60.18%
May. 20 Jefferies Adjusts Zydus Lifesciences' Price Target to INR1,070 From INR750, Keeps at Hold MT
May. 17 Transcript : Zydus Lifesciences Limited, Q4 2024 Earnings Call, May 17, 2024

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Zydus Lifesciences Limited Proposes Final Dividend for the Financial Year Ended on March 31, 2024, Payable on or After August 13, 2024
CI
Zydus Lifesciences Limited Reports Earnings Results for the Full Year Ended March 31, 2024
CI
Zydus Lifesciences Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024
CI
Zydus Lifesciences Gets US FDA Nod to Market Dexamethasone Tablets
MT
India's Cipla open to partnering with Eli Lilly to market their obesity drugs, CEO says
RE
Zydus Lifesciences Limited Announces Completion of Enrolment for EPICS IIITM Phase 2B/3 Trial Evaluating Saroglitazar Mg in Treatment of Primary Biliary Cholangitis
CI
Zydus Lifesciences Gets US FDA Final Nod for Acne Treatment Gel
MT
Zydus Lifesciences Limited Receives Final Approval from USFDA for Dapsone Gel, 7.5%
CI
Zydus Lifesciences Arm Acquires Eiger BioPharmaceuticals' Progeria Drug
MT
Weak March Quarter Earnings Weigh Down Indian Equities on Friday
MT
Zydus Lifesciences Limited Receives Final Approval from USFDA for Tretinoin Cream USP, 0.1%
CI
Zydus Lifesciences Gets 10 Observations from US FDA After Jarod, India Manufacturing Site Inspection
MT
Zydus Lifesciences' Desidustat Tablets Get Nod from China Regulator
MT
Zydus Lifesciences Limited Announces New Drug Application of Zydus' Innovative Drug Desidustat Tablets by China Medical System Holdings Limited Accepted in China
CI
Zydus Lifesciences Limited Launches Mirabegron Extended-Release Tablets in the U.S
CI
Zydus Arm Get UK Drug Regulator's Marketing Approval for Nulibry as MoCD Type A Treatment
MT
Zydus Lifesciences Launches Generic Drug for Overactive Bladder in US
MT
Zydus Receives Approval from WHO International Non-Proprietary Names for Usnoflast as Recommended Name for ZYIL1
CI
Zydus Gets Four Observations from US FDA for Oncology Injectable Plant
MT
Zydus Lifesciences Limited Receives Tentative Approval from USFDA for Letermovir Tablets, 240 Mg and 480 Mg
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ZYDUSLIFE Stock
  4. News Zydus Lifesciences Limited
  5. Highlights
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW